Daniel LeSueur - Sep 3, 2024 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Signature
/s/ Benjamin Landry, as Attorney-in-Fact
Stock symbol
HCAT
Transactions as of
Sep 3, 2024
Transactions value $
-$74,519
Form type
4
Date filed
9/5/2024, 04:42 PM
Previous filing
Aug 7, 2024
Next filing
Oct 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Tax liability -$12.8K -1.76K -1.17% $7.27 148K Sep 3, 2024 Direct F1
transaction HCAT Common Stock Sale -$61.7K -8.14K -5.49% $7.58 140K Sep 4, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Issuer's Restricted Stock Units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
F2 The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 7, 2024 in accordance with Rule 10b5-1.